my private podcast channel
The pullback sent Wall Street’s “fear index” up over 10 percent. Plus: Tesla stock falls after Norway rejects Elon Musk’s pay package. Katherine Sullivan hosts.
Sign up for the WSJ's free What's News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus: AMD reports sharp increases in profit and sales. Rivian Automotive records a jump in third-quarter revenue. And Nintendo boosts guidance for the full year. Julie Chang hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus: First Brands’ new management accuses founder Patrick James of fraud. And Stellantis’s Chrysler recalls over 300,000 hybrid Jeeps over battery fire risks. Zoe Kuhlkin hosts.
Sign up for WSJ’s free What’s News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Bonus Episode for Nov. 4. The weight-loss-drug arms race is only heating up, as Novo Nordisk attempts to snatch drugmaker Metsera away from Pfizer. But can either company compete with Zepbound seller Eli Lilly? WSJ reporter Peter Loftus discusses what earnings from Big Pharma, including AbbVie, Bristol Myers Squibb and Merck, say about the future of the industry and how companies are responding to President Trump’s drug-pricing plans, including TrumpRx.
WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies’ earnings reports and analyst calls to find out what’s going on under the hood of the American economy.
Sign up for the WSJ's free Markets A.M. newsletter.
Further Reading:
Novo Nordisk Sweetens Offer for Metsera - WSJ
Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal
Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk
The Day Pharma’s Weight-Loss Gold Rush Intensified
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand
Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera
Novo Nordisk to Shake Up Board After Obesity-Market Challenges
Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings
AbbVie Lifts Profit Outlook as Sales Rise
Bristol Myers Squibb Profit Soars, Raises Revenue Guidance
Merck Profit Rises on Strong Keytruda Demand
GSK Lifts Guidance After Specialty Medicines Boost Sales
Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead
Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise
J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus: Spotify adds subscribers in the third quarter. And Uber logs higher quarterly profit and revenue. Zoe Kuhlkin hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus: two major investors reject Elon Musk’s $1 trillion pay package. And, Starbucks sells a majority stake in its China business. Caitlin McCabe hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
A.M. Edition for Nov. 4. It is election day with voters heading to the polls in states including New York, Virginia and New Jersey. WSJ’s John McCormick says that although Democrats are expected to win all three races, it will not necessarily ease the divided party’s troubles. Plus, WSJ’s Gavin Bade says there is a lot at stake for President Trump as his tariffs are set to go before the Supreme Court. And two major investors reject Elon Musk’s $1 trillion pay deal. Caitlin McCabe hosts.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Rural parts of the country are getting an economic boost thanks to the construction of giant data centers. WSJ reporter David Uberti visits Umatilla, Oregon to look into whether the boom will last. Plus, the Journal’s auto columnist, Dan Neil, goes for a ride in a flying car. Katie Deighton hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Amazon closes at a record high following an OpenAI deal. Plus: Kimberly-Clark agrees to buy Tylenol maker Kenvue. Katherine Sullivan hosts.
Sign up for the WSJ's free What's News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus: Microsoft secures new computing power capacity in deal with data center company IREN. And Palantir Technologies reports another quarter of record revenue, while shares of Amazon close at a new all-time high. Julie Chang hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices